Clinical trials

Condition   Drug Name  
Study (-)-Epigallocatechin gallate in rosacea
Design Randomized; Double-blind
Patients 100
Treatment Regimen Placebo; (-)-Epigallocatechin gallate top. b.i.d. x 4 wks
Conclusions (-)-Epigallocatechin gallate was associated with a significantly higher reduction in mean inflammatory lesion count compared to placebo and was safe in patients with papulopustular rosacea
Reference(s) Management of papulopustular rosacea with 2% green tea extract (-)EGCg hydrophilic cream. A placebo-controlled, double-blind study
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P3.
Author and Affiliation Syed, T., Wong, W.H.W., Govil, V., Aly, R., Ahmad, S.A.